Henriette Wennicke
Fortune : 923 517 $ au 31/05/2026
Fortune : 923 517 $ au 31/05/2026
Henriette Wennicke currently works at Zealand Pharma A, as Chief Financial Officer & Executive Vice President from 2022.
Ms. Wennicke also formerly worked at Novo Nordisk A, as Director-Research & Development Business Support from 2014 to 2017, GN Store Nord A, as Vice President, Head-Investor Relations & Treasury from 2021 to 2022, and GN Hearing A, as Vice President & Head-Global Finance from 2019 to 2021.
Ms. Wennicke received her graduate degree from Copenhagen Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,03% | 31/12/2025 | 18 204 ( 0,03% ) | 923 517 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ZEALAND PHARMA A/S | Directeur Financier/CFO | 01/11/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| GN STORE NORD A/S | Investor Relations Contact | 01/11/2022 |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Directeur Financier/CFO | 01/01/2021 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
GN Store Nord A/S
GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national